Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-08-18

Clinical Trial Update: Study of the Treatment of Tendinopathy Unruptured of Rotator Cuff by Intramuscular Injection of Botulinum Toxin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is studying intramuscular botulinum toxin for treating rotator cuff tendinopathy (unruptured rotator cuff).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Versailles Hospital | Conditions: Tendinopathy Rotator Cuff | Phase 2 | Status: UNKNOWN